Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals submits media release

11 Jul 2019 Evaluate

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India’, which is self explanatory.   

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..